Liquid Biopsy

Health Care Sector Icon

How do you begin to quantify the significance of liquid biopsy as an investment theme?

Liquid Biopsies are blood-based tests for three major uses: early detection of cancer in high-risk individuals, optimization of a clinician’s drug treatment decision based on specific genetic information, and monitoring of responses in patients undergoing treatment, along with detection of cancer recurrence as quickly as possible in cancer survivors. In 2020, we expect more data, pre-approvals, more products and more growth in a significant market opportunity even in the US alone. We estimate that roughly50% of cancer trials today include some components of personalized medicine and liquid biopsy tools representing a substantial actionable part of that trend.

What we’re watching:

  • Clinical data and validations
  • Reimbursement progress
  • Biopharma partnership agreements
Themes 2020

15 Themes to Focus on 2020: A Handbook for Portfolio Managers

Download the Handbook
15M

Cancer survivors in the us

1.5M

New cancer diagnoses in the us each year

>300M

People in the us that could benefit from early cancer screening tools

<5%

Estimated current penetration of patients eligible to use liquid biopsy tools as a cancer companion diagnostic

Research

Podcast
Woman applying concealer to face.

Beauty School With COTY, A Diversified Beauty Powerhouse

Podcast
American flags hung high from flag poles blowing in the clear blue sky.

National Security Need-To-Know Podcast Series

Podcast
American Flag perched on the top of the United States capital building during the day.

Three Areas To Watch: Fiscal Packages/Shutdown Risk, Special Election 2024 Impact & Q1 Catalyst Calendar

Events

New York, NY

Jun 04, 2024

8th Annual Future of the Consumer Conference

New York, NY

May 29, 2024

52nd Annual Technology, Media & Telecom Conference

Virtual

Mar 19, 2024

3rd Annual Fiber-to-the-Home Symposium